RE:Brent Zettl Video InterviewI have to say, I agree. This deal is nuts for ACB. CMED is not a good deal for ACB shareholders. I think the SEC will rule against ACB. That will provide the out. ACB shares should go up, while CMED’s should go down. ACB’s got a lot of other companies to look at and they are good and cheap.